These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32812130)

  • 21. Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.
    Breukink MB; Downes SM; Querques G; van Dijk EHC; den Hollander AI; Blanco-Garavito R; Keunen JEE; Souied EH; MacLaren RE; Hoyng CB; Fauser S; Boon CJF
    Trials; 2015 Sep; 16():419. PubMed ID: 26390920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy.
    Russo A; Turano R; Morescalchi F; Gambicorti E; Cancarini A; Duse S; Costagliola C; Semeraro F
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1141-1148. PubMed ID: 28283732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subthreshold diode micropulse laser versus observation in acute central serous chorioretinopathy.
    Arora S; Sridharan P; Arora T; Chhabra M; Ghosh B
    Clin Exp Optom; 2019 Jan; 102(1):79-85. PubMed ID: 30058731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of subthreshold micropulse laser for chronic central serous chorioretinopathy: A meta-analysis.
    Li X; Long H; Hu Q
    Photodiagnosis Photodyn Ther; 2022 Sep; 39():102931. PubMed ID: 35636735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors of visual outcome in central serous chorioretinopathy treated with subthreshold micropulse laser therapy.
    Huang Y; Li G; Ge L; Lin B
    Lasers Med Sci; 2024 Oct; 39(1):256. PubMed ID: 39387944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients.
    Park YG; Kang S; Kim M; Yoo N; Roh YJ
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1375-1383. PubMed ID: 28421342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two laser power levels in the subthreshold micropulse yellow laser treatment of acute central serous chorioretinopathy.
    Qin L; Li D; Zhou Y; Zhang H; Zhang G; Zhang X; Shi W
    Photodiagnosis Photodyn Ther; 2024 Oct; 49():104323. PubMed ID: 39214344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.
    Scholz P; Altay L; Fauser S
    Eye (Lond); 2016 Oct; 30(10):1371-1377. PubMed ID: 27391938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective retina therapy (SRT) in patients with therapy refractory persistent acute central serous chorioretinopathy (CSC): 3 months functional and morphological results.
    Büttner M; Luger B; Abou Moulig W; Junker B; Framme C; Jacobsen C; Knoll K; Pielen A;
    Graefes Arch Clin Exp Ophthalmol; 2021 Jun; 259(6):1401-1410. PubMed ID: 33205239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological parameters predicting subthreshold micropulse laser effectiveness in central serous chorioretinopathy.
    Kiraly P; Smrekar J; Jaki Mekjavić P
    Lasers Med Sci; 2022 Oct; 37(8):3129-3136. PubMed ID: 35579726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy.
    Abd Elhamid AH
    Clin Ophthalmol; 2015; 9():2277-83. PubMed ID: 26664043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subthreshold Micropulse Laser (577 nm) Treatment in Chronic Central Serous Chorioretinopathy.
    Scholz P; Ersoy L; Boon CJ; Fauser S
    Ophthalmologica; 2015; 234(4):189-94. PubMed ID: 26406874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 532 nm versus 810 nm subthreshold micropulse laser in treatment of non-resolving central serous chorioretinopathy: A randomized controlled trial.
    Ambiya V; Kumar A; Seth S; Kumar P; Oli A
    Med J Armed Forces India; 2024; 80(5):535-540. PubMed ID: 39309578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central Serous Chorioretinopathy: Morphological and Functional Outcome after Subthreshold Thermal Laser Coagulation with a Frequency-Doubled Nd:YAG Continuous-Wave Laser.
    Enders C; Lang GE; Mayer B; Werner JU
    Ophthalmologica; 2022; 245(1):59-68. PubMed ID: 34517369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Navigated micropulse laser for central serous chorioretinopathy: Efficacy, safety, and predictive factors of treatment response.
    Amoroso F; Pedinielli A; Cohen SY; Jung C; Chhablani J; Astroz P; Colantuono D; Semoun O; Capuano V; Souied EH; Miere A
    Eur J Ophthalmol; 2022 Sep; 32(5):2810-2818. PubMed ID: 34846180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between outer retinal layer thickness and cone density in patients with resolved central serous chorioretinopathy.
    Nakamura T; Ueda-Consolvo T; Oiwake T; Hayashi A
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2347-2354. PubMed ID: 27255458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of 532 nm transfoveal subthreshold micropulse laser in non-resolving central serous chorioretinopathy with subfoveal leaks.
    Ambiya V; Kumar A
    Ther Adv Ophthalmol; 2020; 12():2515841420945107. PubMed ID: 32995706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study.
    Lanzetta P; Furlan F; Morgante L; Veritti D; Bandello F
    Eur J Ophthalmol; 2008; 18(6):934-40. PubMed ID: 18988165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subthreshold Micropulse Laser Versus Oral Spironolactone in Chronic Central Serous Chorioretinopathy: A Quasi-Randomized Controlled Trial.
    Gao S; Ge G; Zhang Y; Zhang M
    Transl Vis Sci Technol; 2024 Aug; 13(8):19. PubMed ID: 39133498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.